a biotechnology development company, which engages in the provision of diversified commercialization platform for protected technologies
Industry Biotechnology
A.I.dvisor tells us that DOMH and ABUS have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DOMH and ABUS's prices will move in lockstep.
Ticker / NAME | Correlation To DOMH | 1D Price Change % | ||
---|---|---|---|---|
DOMH | 100% | +1.89% | ||
ABUS - DOMH | 28% Poorly correlated | +3.10% | ||
ACLX - DOMH | 25% Poorly correlated | -3.81% | ||
NKTR - DOMH | 25% Poorly correlated | -3.12% | ||
LGND - DOMH | 25% Poorly correlated | -4.58% | ||
ELVN - DOMH | 24% Poorly correlated | +1.46% | ||
More |